Celyad Oncology Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	0.79	4.2	7	12.45	30.02	17.23
Cash & Short-Term Investments	0.79	4.2	7	12.45	30.02	17.23
Cash Growth	-87.32%	-40.03%	-43.72%	-58.54%	74.18%	-56.19%
Accounts Receivable	0.02	0.13	0.38	0.91	0.42	0.4
Other Receivables	0.74	0.78	2.4	0.35	1.92	0.51
Receivables	0.76	0.91	2.78	1.26	2.34	0.91
Inventory	0.26	0.42	-	-	-	-
Prepaid Expenses	0.61	0.95	1.26	0.67	1.69	1.34
Other Current Assets	0.05	0.05	0.08	0.45	0.25	0.22
Total Current Assets	2.46	6.52	11.12	14.83	34.29	19.71
Property, Plant & Equipment	1.34	1.49	1.83	0.31	3.25	4.12
Goodwill	-	-	-	-	0.88	0.88
Other Intangible Assets	0.02	0.02	0.05	0.46	34.81	34.75
Long-Term Accounts Receivable	-	-	-	-	2.21	2.12
Long-Term Deferred Charges	0.34	0.38	0.34	0.41	0.47	0.54
Other Long-Term Assets	1.55	1.52	2.94	3.72	4.03	3.97
Total Assets	5.7	9.93	16.28	19.72	79.94	66.08
Accounts Payable	0.92	1.23	1.24	4.75	6.61	4.74
Accrued Expenses	0.39	0.44	0.5	1.39	2.13	1.97
Current Portion of Long-Term Debt	-	-	-	-	-	0.04
Current Portion of Leases	0.08	0.14	0.16	0.14	0.9	1.08
Current Unearned Revenue	1.59	0.08	0.31	0.89	1.1	1.84
Other Current Liabilities	0.74	0.95	0.73	3.26	3.09	2.18
Total Current Liabilities	3.72	2.85	2.93	10.43	13.83	11.83
Long-Term Leases	0.75	0.76	0.9	0.12	1.73	2.53
Pension & Post-Retirement Benefits	0	0	0	0.01	0.05	0.61
Other Long-Term Liabilities	4.33	5.81	6.14	4.84	20.69	20.12
Total Liabilities	8.8	9.42	9.98	15.4	36.3	35.09
Common Stock	8.22	8.22	32.95	78.59	78.59	48.51
Additional Paid-In Capital	-	-	-	6.32	6.32	43.35
Retained Earnings	-367.87	-364.2	-358.37	-349.95	-309	-283.04
Comprehensive Income & Other	356.55	356.49	331.73	269.36	267.73	222.17
Shareholders' Equity	-3.1	0.51	6.3	4.32	43.64	30.99
Total Liabilities & Equity	5.7	9.93	16.28	19.72	79.94	66.08
Total Debt	0.83	0.91	1.06	0.26	2.63	3.64
Net Cash (Debt)	-0.04	3.3	5.95	12.19	27.39	13.6
Net Cash Growth	-	-44.59%	-51.22%	-55.49%	101.43%	-61.13%
Net Cash Per Share	-0.00	0.08	0.23	0.54	1.76	0.98
Filing Date Shares Outstanding	41.43	41.43	41.43	22.59	22.59	14.21
Total Common Shares Outstanding	41.43	41.43	41.43	22.59	22.59	13.94
Working Capital	-1.26	3.67	8.19	4.4	20.47	7.87
Book Value Per Share	-0.07	0.01	0.15	0.19	1.93	2.22
Tangible Book Value	-3.12	0.49	6.26	3.86	7.95	-4.64
Tangible Book Value Per Share	-0.08	0.01	0.15	0.17	0.35	-0.33
Machinery	-	0.83	0.89	1.28	4.01	3.81
Leasehold Improvements	-	0.64	0.64	0.18	4.06	4.03

Source: S&P Global Market Intelligence. Standard template. Financial Sources.